Partner With Us NRI

Details you don’t want to miss

Issue size

To be announced

Issue Period

To be announced

Price band

To be announced

Market lot / Multiples

To be announced

Healthium Medtech Ltd Overview

The company is a global medtech company focused on products used in surgical, post-surgical and chronic care.

They operate across three key markets - India, UK and rest of the world and four focus areas, namely - advanced surgery, urology, arthroscopy and wound care.

One in five surgeries conducted globally uses a Healthium product as of March 31, 2021 (Source: Company DRHP & Frost & Sullivan Report).

Read More

Ask Our Analyst

Please enter valid captcha

Strengths & Risks associated

Top 0 Strengths

  • 1

    A leading medtech company with global reach

    One in five surgeries conducted globally uses a Healthium product as of March 31, 2021 (Source: Frost & Sullivan Report). As of Fiscal 21, they are a market leader in the surgical consumables market in India, the global surgical needles market, and the urology collection devices market in UK (Source:Frost & Sullivan Report).

  • 2

    An innovative and comprehensive product suite driven by focused research and development efforts

    Have over 52,000 SKUs across different products, which enables them to cater to a wide variety of procedures and applications.

  • 3

    Extensive sales network and market access across the focus areas with long-standing relationships with customers

    Have the largest direct sales force among independent medical device companies in India. (Source: Frost & Sullivan Report). Have over 350 employees in the direct sales force as of July 2021.

Top 0 risks

  • 1

    Subject to complex laws and governmental regulations governing their products and business operations

    Compliance with these laws and regulations requires significant time and cost, and any adverse regulatory action may adversely affect the financial condition, cash flows and business operations.

  • 2

    Dependent on the success of their research and development activities

    Despite investments in R&D of Rs. 146.51 mn in FY21 , the efforts may not result in the discovery or successful development of new products.


  • Net Worth
  • Total Income
  • Net cash inflows/(outflows)
  • Total borrowings
  • Restated Profit
  • Basic Earning per Share (EPS)

Net Worth

Total Income

Net cash inflows/(outflows)

Total borrowings

Restated Profit

Basic Earning per Share (EPS)

Industry Trends

Subscription Status

Retail Individual Investor
Non-Institutional Investor
Qualified Institutional Buyers

Past performance of IPOs

Why invest in IPO through ICICIdirect

Paperless Applications

Hassle-free refunds

Convenient investments within a few clicks

Multiple modes of application


An Initial Public Offering (IPO) is when a company issues common stock or shares to the public for the first time. It is the process where a privately held company becomes a publicly traded company with the initial sale of its stock. An IPO is a tool that companies use to secure capital through investments for future use. In most instances, this investment is used to expand or improve the business.

A price band is a price floor and a cap between which a seller will let buyers place bids on a security, usually during an initial public offering (IPO).

Minimum Order Quantity, as name says, is the minimum number of shares investors can apply while bidding in an IPO. If investors want to bid for more shares, they can apply in multiples of IPO market lot (lot Size or IPO bid lot) of shares.

If an investor wants to place bids for less than Rs.2 lacs, he needs to apply in the Retail segment. If an investor wants to bid for more than Rs.2 lacs, he needs to apply in the HNI segment.

Cut-off price is the offer price, finalized by a company in consultation with the book running lead managers (BRLMs), which could be any price within the price band. Applying on Cut-off price means the investor is ready to pay whatever price is decided by the company at the end of the book-building process.

When applying at a cut-off price, an investor has to pay the highest price while placing the bid. If a company decides the final price lower than the highest price asked for IPO, the remaining amount is returned to the retail investor.

An investor can apply in all Mainboard IPOs through ICICIdirect. However, if the investor wants to apply in SME IPOs, he/she can do it through the net banking portal of ICICI Bank.

ASBA stands for "Applications Supported by Blocked Accounts". At the time of bidding, investors’ account is blocked to the extent of the bid amount and debited only at the time of allotment. This facility is being offered by ICICIDirect in affiliation with ICICI Bank Limited.

In other payment options, the bid amount is debited when investors’ bid application is placed with the stock exchanges. Under the ASBA process, the amount will be debited from investors’ bank account to the extent of successful allotment at the time of allotment. Until such allotment, the amount will remain blocked in investors’ bank account.

Application under this facility can be placed only for Book Built Public Issues.

An investor can place maximum of 3 bids in an issue.

The investor with Demat account in ICICIdirect can apply in an IPO by logging in to his ICICIdirect Account. The investor needs to select IPO and then the name of the IPO in which he would like to apply. Given below is the path:

Login to ICICIdirect account >> IPO >> Name of IPO

Investor can apply in the retail section of an IPO through iDirect Portal even if he has a 2-in-1 account (Demat, Trading Accounts) with us and Bank account with third party.

Yes, the investor can revise or withdraw the bids after application. It can be done only once the order is executed. The investor needs to go to the IPO Order Book and select the Transaction Id and then click on Withdraw Application/ Revise Bid. The application in the non- institutional category cannot be withdrawn but can only be revised.

However, this needs to be done during the issue itself and cannot be done after the issue is closed. In case of ASBA applications, for upward revision of bid, additional lien will be marked to the extent of incremental amount. However, in case of downward revision, differential money blocked earlier will not be released. Such amount, if any, will be released after allotment

No, one person cannot apply multiple times with same Demat/PAN for an IPO. If an investor applies in an IPO though multiple applications with same Demat account or same PAN Number, his applications will be rejected.

If an investor would like to place order for multiple applications, he/she can apply with his/her family member's name. But, all eligible family members should have a Demat account and a PAN number.

In cases where issue is over-subscribed, bidding for more than 1 lot from the same account doesn’t help as maximum of only 1 lot can be provided against each application. However, if the investor applies for 1 lot from different accounts, the probability of allocation of shares increases.